Cargando…
The War on Diabetic Retinopathy: Where Are We Now?
Diabetic retinopathy (DR), a major cause of blindness in working-age adults, is emerging as a major public health issue worldwide, in particular in low- and middle-income countries (LMIC). Traditionally, the management of DR has been on tertiary-level treatment (eg, laser, anti-VEGF injections and s...
Autores principales: | Wong, Tien Y., Sabanayagam, Charumathi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903323/ https://www.ncbi.nlm.nih.gov/pubmed/31789647 http://dx.doi.org/10.1097/APO.0000000000000267 |
Ejemplares similares
-
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
por: Lee, Ryan, et al.
Publicado: (2015) -
Mechanism of diabetic neuropathy: Where are we now and where to go?
por: Yagihashi, Soroku, et al.
Publicado: (2011) -
Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018) -
Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023) -
Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)